Article Correctness Is Author's Responsibility: Researchers show genetic mutations in advanced lung cancer may predict improved outcomes

Newswise imageAccording to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).